Efficacy, safety, and tolerability of valsartan/hydrochlorothiazide in Asian patients with essential hypertension

被引：0
|
作者：
Wen-Ter Lai
Jeong-Euy Park
Neelesh Dongre
Jackson Wang
机构：
[1] Kaohsiung Medical University Hospital,Division of Cardiology, Department of Internal Medicine
[2] Samsung Medical Center,Cardiology Division
[3] Novartis Pharma AG,Scientific Operations Department, Asia
[4] Novartis (Taiwan) Co.,Pacific, Middle East & African Countries
[5] Ltd.,Scientific Operations Department
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
Asian; combination therapy; efficacy; hypertension; tolerability; valsartan/hydrochlorothiazide single pill;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：427 / 438
页数：11
相关论文
共 50 条
  • [31] Efficacy and tolerability of the combination of candesartan cilexetil and hydrochlorothiazide in systemic hypertension.
    Papademetriou, V
    Michelson, EL
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 126A - 126A
  • [32] Valsartan/hydrochlorothiazide - A review of its pharmacology, therapeutic efficacy and place in the management of hypertension
    Wellington, K
    Faulds, DM
    DRUGS, 2002, 62 (13) : 1983 - 2005
  • [33] Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension
    Sun, Ning-L.
    Zhu, Jun-R.
    Zhao, Yanxing
    Tu, Ying-M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (10) : 2863 - 2871
  • [34] Efficacy and safety of omapatrilat with hydrochlorothiazide for the treatment of hypertension in subjects nonresponsive to hydrochlorothiazide alone
    Ferdinand, K
    Saini, R
    Lewin, A
    Yellen, L
    Barbosa, JA
    Kushnir, E
    AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (08) : 788 - 793
  • [35] Evaluation of Pharmacokinetic Interactions Between Amlodipine, Valsartan, and Hydrochlorothiazide in Patients With Hypertension
    Bhad, Prafulla
    Ayalasomayajula, Surya
    Karan, Rajesh
    Leon, Selene
    Riviere, Gillies-Jacques
    Sunkara, Gangadhar
    Jarugula, Venkateswar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (06) : 933 - 942
  • [36] Amlodipine/Valsartan/Hydrochlorothiazide Fixed-Dose Combination in Hypertension
    Deeks, Emma D.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (06) : 411 - 418
  • [37] Efficacy and safety of olmesartan and hydrochlorothiazide versus telmisartan and hydrochlorothiazide in newly diagnosed patients with mild-to-moderate hypertension
    Ramesh, Revathi
    Sarala, N.
    Venkatarathnamma, P. N.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2018, 8 (01) : 38 - 43
  • [38] Comparison of the efficacy and tolerability of telmisartan and enalapril in patients of mild to moderate essential hypertension
    Akat, Pramod B.
    Bapat, Tushar R.
    Murthy, Mangala B.
    Karande, Vitthal B.
    Burute, Shreyas R.
    INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (03) : 153 - 156
  • [39] A COMPARISON OF THE EFFICACY OF CILAZAPRIL VERSUS CILAZAPRIL PLUS HYDROCHLOROTHIAZIDE IN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    KELLAWAY, GSM
    ATKINSON
    BEVIN
    CHOY
    DELACEY
    DINE
    DOERR
    DYKES
    EAMES
    EDWARDS
    FORD
    GARE
    HAYCOCK
    HAYWOOD
    HENDY
    HUNTER
    LOAN
    LOWE
    MULES
    NEALIE
    PARKER
    POLLOCK
    RASALINGHAM
    REEKIE
    RICHMOND
    SANDIN
    STAUB
    SUCKLING
    SURYNT
    VICKERS
    WELLINGTON
    WELLS
    WONG
    YOUNG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (04) : 377 - 379
  • [40] Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with Stage 2 hypertension
    Flack, John M.
    Yadao, Anthony M.
    Purkayastha, Das
    Samuel, Rita
    White, William B.
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2012, 6 (02) : 142 - 151
12345